Medrol and Calan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Medrol (methylprednisolone) and Calan (verapamil hydrochloride). Common drug interactions include hyperdynamic left ventricle among females and dyspnoea among males.

The phase IV clinical study analyzes what interactions people have when they take Medrol and Calan. It is created by eHealthMe based on reports of 24 people who take the same drugs from the FDA, and is updated regularly.

What is Medrol?

Medrol has active ingredients of methylprednisolone. It is often used in rheumatoid arthritis. eHealthMe is studying from 24,443 Medrol users. Check the latest studies of Medrol.

What is Calan?

Calan has active ingredients of verapamil hydrochloride. It is often used in high blood pressure. eHealthMe is studying from 3,916 Calan users. Check the latest studies of Calan.

On Jul, 14, 2026

24 people who take Medrol and Calan together, and have interactions are studied.

What are the common drug interactions of Medrol and Calan, by gender? *:

female:

Hyperdynamic left ventricle
Hyperhidrosis (abnormally increased sweating)
Hypersensitivity
Hypovitaminosis (any of several diseases caused by deficiency of one or more vitamins)
Influenza
International normalised ratio increased
Intra-abdominal haematoma (intra-abdominal localized swelling filled with blood)
Loss of consciousness
Lymphadenopathy (disease or enlargement of lymph nodes)
Metastases to lung (cancer spreads to lung)

male:

Dyspnoea (difficult or laboured respiration)
Pneumonia
Cardiac enzymes increased
Chronic kidney disease
Chronic obstructive airways disease
Cough
Decreased appetite
Dehydration (dryness resulting from the removal of water)
Electrocardiogram abnormal
Haematocrit decreased

What are the common drug interactions of Medrol and Calan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

Chronic kidney disease
Renal failure (kidney dysfunction)

40-49:

Hepatocellular damage (liver damage)

50-59:

Hypersensitivity
Influenza
Lymphadenopathy (disease or enlargement of lymph nodes)
Metastases to lung (cancer spreads to lung)
Nasopharyngitis (inflammation of the nasopharynx)
Oropharyngeal pain
Oxygen saturation decreased
Pyrexia (fever)
Rash
Rash pruritic (redness with itching)

60+:

Depression
Aneurysm (enlargement of an artery caused by a weakening of the artery wall)
Nausea (feeling of having an urge to vomit)
Colitis (inflammation of colon)
Death
Hyperlipidaemia (presence of excess lipids in the blood)
Hypokalaemia (low potassium)
Abdominal discomfort
Adverse event
Asthma

What are the existing conditions these people have? *

Oedema Peripheral (superficial swelling): 6 people, 25.00%
Lung Cancer - Non-Small Cell (lung cancer): 6 people, 25.00%
Pain: 2 people, 8.33%

* Approximation only. Some reports may have incomplete information.

Do you take Medrol and Calan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously